Kidney Disease Stage Independently Predicts Cognitive Decline Risk, Large Cohort Study Fin

Chronic kidney disease and cognitive decline share a set of underlying risk factors - high blood pressure, diabetes, cardiovascular disease - so their co-occurrence is not surprising. What has been less clear is whether kidney disease severity itself, independent of those shared risk factors, predicts how likely a person is to develop cognitive impairment. A cohort study published in JAMA Network Open provides the most systematic evidence yet that it does.

The study, led by corresponding author Tanika N. Kelly, PhD, MPH, of the University of Illinois Chicago, tracked patients across the full spectrum of CKD staging and measured the incidence of newly diagnosed cognitive impairment. The central finding is straightforward: as CKD stage advanced, so did cognitive impairment risk. The relationship held across the CKD spectrum, not just at end-stage kidney disease where the connection has been more widely recognized.

Why Kidneys and Brains May Be Linked

The mechanisms that might connect kidney function to cognitive health are multiple and partially overlapping. Declining kidney function leads to accumulation of uremic toxins - waste products that damaged kidneys fail to filter - some of which can cross the blood-brain barrier and directly affect neuronal function. CKD is also strongly associated with accelerated vascular disease: the same endothelial dysfunction and arterial stiffening that damages kidney filtration units also impairs cerebral blood flow and increases white matter lesion burden in the brain.

Anemia, a common complication of CKD as erythropoietin production falls, reduces oxygen delivery to brain tissue. Chronic inflammation - a feature of progressive CKD - may promote neuroinflammatory processes. The relative contribution of each mechanism remains an active area of research, and the study does not resolve it. What it establishes is that the aggregate effect is large enough to produce a statistically significant, dose-dependent relationship between CKD stage and cognitive risk.

What the Staging Relationship Means Clinically

CKD is staged from 1 through 5 based primarily on estimated glomerular filtration rate (eGFR), with lower eGFR reflecting more impaired kidney function. Stage 5 is end-stage kidney disease, typically requiring dialysis or transplant. Most research on CKD and cognitive decline has focused on patients at Stage 4 and 5, where cognitive impairment rates are substantially elevated. The cohort study's contribution is documenting that the association extends earlier in the disease trajectory - that patients at Stage 2 and 3 already face meaningfully elevated cognitive risk compared to those at Stage 1.

That has practical implications for clinical monitoring. Current nephrology practice does not typically include routine cognitive screening in earlier CKD stages. If kidney function itself is an independent predictor of cognitive deterioration starting in middle stages of disease, waiting for obvious cognitive symptoms to emerge before investigating may mean intervening too late.

The authors suggest the findings underscore CKD severity as a risk factor for cognitive decline across the full CKD spectrum and point to the importance of health care professionals monitoring cognitive function at earlier stages than currently standard.

Study Limitations

Cohort studies establish association, not causation. The analysis accounted for major confounders, but the possibility of residual confounding cannot be eliminated. Patients who die before cognitive impairment is measured are not captured, which may underestimate the true relationship in the most severely ill. The study also does not address which cognitive domains are most affected - memory, executive function, processing speed - or whether particular patterns of cognitive change are more common at specific CKD stages. That granularity would be valuable for designing screening tools and early interventions.

The full study is available in JAMA Network Open (doi:10.1001/jamanetworkopen.2025.59834).